259 related articles for article (PubMed ID: 29374563)
1. Does the use of melatonin overcome drug resistance in cancer chemotherapy?
Asghari MH; Ghobadi E; Moloudizargari M; Fallah M; Abdollahi M
Life Sci; 2018 Mar; 196():143-155. PubMed ID: 29374563
[TBL] [Abstract][Full Text] [Related]
2. Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment.
Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Najafi M; Sahebkar A
J Cell Physiol; 2019 May; 234(5):5613-5627. PubMed ID: 30238978
[TBL] [Abstract][Full Text] [Related]
3. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
[TBL] [Abstract][Full Text] [Related]
4. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
[TBL] [Abstract][Full Text] [Related]
5. The potential utility of melatonin in the treatment of childhood cancer.
Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
[TBL] [Abstract][Full Text] [Related]
6. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.
Blask DE; Sauer LA; Dauchy RT
Curr Top Med Chem; 2002 Feb; 2(2):113-32. PubMed ID: 11899096
[TBL] [Abstract][Full Text] [Related]
7. Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin.
Fan L; Sun G; Ma T; Zhong F; Lei Y; Li X; Wei W
J Pineal Res; 2013 Sep; 55(2):184-94. PubMed ID: 23711089
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targets of cancer drugs: Modulation by melatonin.
Moloudizargari M; Moradkhani F; Hekmatirad S; Fallah M; Asghari MH; Reiter RJ
Life Sci; 2021 Feb; 267():118934. PubMed ID: 33385405
[TBL] [Abstract][Full Text] [Related]
9. Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review.
Mortezaee K; Najafi M; Farhood B; Ahmadi A; Potes Y; Shabeeb D; Musa AE
Life Sci; 2019 Jul; 228():228-241. PubMed ID: 31077716
[TBL] [Abstract][Full Text] [Related]
10. The validity of melatonin as an oncostatic agent.
Panzer A; Viljoen M
J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
[TBL] [Abstract][Full Text] [Related]
11. Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation.
Sanchez-Barcelo EJ; Mediavilla MD; Alonso-Gonzalez C; Reiter RJ
Expert Opin Investig Drugs; 2012 Jun; 21(6):819-31. PubMed ID: 22500582
[TBL] [Abstract][Full Text] [Related]
12. Melatonin in clinical oncology.
Bartsch C; Bartsch H; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():30-8. PubMed ID: 12019349
[TBL] [Abstract][Full Text] [Related]
13. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.
Zare H; Shafabakhsh R; Reiter RJ; Asemi Z
J Ovarian Res; 2019 Mar; 12(1):26. PubMed ID: 30914056
[TBL] [Abstract][Full Text] [Related]
14. Melatonin: An important anticancer agent in colorectal cancer.
Mirza-Aghazadeh-Attari M; Mohammadzadeh A; Mostavafi S; Mihanfar A; Ghazizadeh S; Sadighparvar S; Gholamzadeh S; Majidinia M; Yousefi B
J Cell Physiol; 2020 Feb; 235(2):804-817. PubMed ID: 31276205
[TBL] [Abstract][Full Text] [Related]
15. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer.
Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
Curr Med Chem; 2017 Nov; 24(35):3829-3850. PubMed ID: 28721827
[TBL] [Abstract][Full Text] [Related]
16. New perspectives in melatonin uses.
Carpentieri A; Díaz de Barboza G; Areco V; Peralta López M; Tolosa de Talamoni N
Pharmacol Res; 2012 Apr; 65(4):437-44. PubMed ID: 22311380
[TBL] [Abstract][Full Text] [Related]
17. Basic mechanisms involved in the anti-cancer effects of melatonin.
Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ
Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257
[TBL] [Abstract][Full Text] [Related]
18. The Role of Melatonin in Colorectal Cancer.
Iravani S; Eslami P; Dooghaie Moghadam A; Moazzami B; Mehrvar A; Hashemi MR; Mansour-Ghanaei F; Mansour-Ghanaei A; Majidzadeh-A K
J Gastrointest Cancer; 2020 Sep; 51(3):748-753. PubMed ID: 31792737
[TBL] [Abstract][Full Text] [Related]
19. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal.
Blask DE; Dauchy RT; Sauer LA
Endocrine; 2005 Jul; 27(2):179-88. PubMed ID: 16217131
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the immune system by melatonin; implications for cancer therapy.
Moslehi M; Moazamiyanfar R; Dakkali MS; Rezaei S; Rastegar-Pouyani N; Jafarzadeh E; Mouludi K; Khodamoradi E; Taeb S; Najafi M
Int Immunopharmacol; 2022 Jul; 108():108890. PubMed ID: 35623297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
